Pms-zolmitriptan Odt (2020-02-26)

PMS-Zolmitriptan ODT Recall Summary PMS-Zolmitriptan ODT tablets are being recalled across Canada due to a product safety issue. This medication is used to treat migraines. The recall affects all patients in Canada who have this drug.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2020-02-26
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b28ce742-9606-4a0b-9079-83442f4a0ac3